Rapid tests and transfusion safety in Niamey, Niger

To evaluate the virological safety of blood components provided by the Niamey blood transfusion center after undergoing rapid tests. Samples found negative with rapid tests (n = 222) were screened by the Abbott Prism assay. Positive samples were confirmed by appropriate methods. Of 222 samples, nine (4.1%) were reactive for all markers. After confirmation, seven samples were positive (i.e., 3.2% false-negative results) : five (2.3%) for the surface antigen of hepatitis B (HBsAg) and two (0.9%) for the antibody directed against the hepatitis C virus (HCV-Ab). No false negative results were observed for HIV-Ab (antibody directed against the Human Immunodeficiency Virus). The performance of the rapid tests used in Niamey to screen for transfusion-transmissible infections is not satisfactory, especially for hepatitis B and C. The use of more sensitive tests should be considered to minimize the risk of contaminating patients receiving blood components.